A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

Clinical trial NCT03914326 · COMPLETED

Trial details

NCT number: NCT03914326
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-06-17
Primary completion: 2024-08-23
Enrollment: 9651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.